Evaluation of a Medication Health Center to Promote Opioid Safety
- Conditions
- Overdose
- Interventions
- Behavioral: MHC Outreach Intervention
- Registration Number
- NCT06456294
- Lead Sponsor
- Kaiser Permanente
- Brief Summary
This study will assess the impact of an opioid safety clinic intervention for patients prescribed chronic opioid therapy. Outcomes are visits to the clinic, naloxone dispensings, Prescription Drug Monitoring reviews, and Urine Drug Screens conducted
- Detailed Description
Given ongoing concerns about the risk of opioid overdose among people taking chronic opioid therapy for pain, Kaiser Permanente Colorado (KPCO) sought to develop a standardized approach to promote opioid safety. Operational stakeholders adapted an existing Opioid Safety Clinic model, tailored it for KPCO's context, and implemented it in three geographically dispersed KPCO clinics with leadership support. The approach was a multidisciplinary "Medication Health Center" to assess patients, educate them about overdose risk, provide naloxone, and ensure adherence to standard monitoring. Operations and the research team then collaborated to assess the effectiveness of the program to inform decisions to scale the program to other regions.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 14
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MHC Early Outreach Intervention MHC Outreach Intervention Early implementation of a MHC outreach intervention program. Clinics in the early outreach intervention arm will be assigned to the MHC Direct patient outreach, where MHC staff will encourage patients to schedule an appointment with the MHC and primary care (PC) staff will be educated to encourage MHC visits.
- Primary Outcome Measures
Name Time Method Number of participants with a Medication Health Center visit Outcomes are assessed in a two-month post-intervention period. Medication Health Center (MHC) Visits will be assessed using data from the electronic medical record.
- Secondary Outcome Measures
Name Time Method Number of participants with a Urine Drug Screens completed Outcomes are assessed in a two-month post-intervention period. Urine Drug Screens Completed are assessed using data from the electronic medical record
Number of participants with a Naloxone dispensing Outcomes are assessed in a two-month post-intervention period. Naloxone dispensings are assessed using data from the electronic medical record
Number of participants with a Prescription Drug Monitoring Program (PDMP) review Outcomes are assessed in a two-month post-intervention period. Prescription Drug Monitoring Program (PDMP) reviews are assessed using data from the electronic medical record
Trial Locations
- Locations (1)
Kaiser Permanente Colorado
🇺🇸Aurora, Colorado, United States